AN2 Therapeutics, Inc. (ANTX)
5.74
-0.24
(-4.01%)
USD |
NASDAQ |
Sep 09, 11:41
AN2 Therapeutics Price : 5.74 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 6.00 | 6.06 | 5.76 | 5.98 | 335287.0 |
| Sep 04, 2026 | 5.97 | 6.06 | 5.85 | 5.89 | 77183.00 |
| Sep 03, 2026 | 6.05 | 6.20 | 5.79 | 5.95 | 199660.0 |
| Sep 02, 2026 | 5.46 | 6.00 | 5.46 | 5.95 | 353562.0 |
| Sep 01, 2026 | 5.53 | 5.67 | 5.40 | 5.48 | 215424.0 |
| Aug 31, 2026 | 5.58 | 5.645 | 5.40 | 5.55 | 124021.0 |
| Aug 28, 2026 | 5.67 | 5.78 | 5.40 | 5.58 | 240866.0 |
| Aug 27, 2026 | 5.46 | 5.79 | 5.46 | 5.74 | 204041.0 |
| Aug 26, 2026 | 5.66 | 5.85 | 5.50 | 5.53 | 287524.0 |
| Aug 25, 2026 | 5.67 | 5.80 | 5.60 | 5.66 | 217707.0 |
| Aug 24, 2026 | 5.82 | 5.82 | 5.59 | 5.63 | 171420.0 |
| Aug 21, 2026 | 5.84 | 5.89 | 5.50 | 5.81 | 225450.0 |
| Aug 20, 2026 | 5.98 | 6.13 | 5.72 | 5.79 | 195335.0 |
| Aug 19, 2026 | 5.97 | 6.045 | 5.775 | 5.96 | 266092.0 |
| Aug 18, 2026 | 5.59 | 5.995 | 5.58 | 5.97 | 215701.0 |
| Aug 17, 2026 | 5.96 | 6.21 | 5.725 | 5.73 | 273766.0 |
| Aug 14, 2026 | 6.04 | 6.205 | 5.94 | 5.99 | 198353.0 |
| Aug 13, 2026 | 6.28 | 6.365 | 5.90 | 5.98 | 298935.0 |
| Aug 12, 2026 | 6.09 | 7.19 | 5.66 | 6.28 | 429197.0 |
| Aug 11, 2026 | 5.92 | 6.09 | 5.800 | 5.87 | 68726.00 |
| Aug 10, 2026 | 5.91 | 6.08 | 5.69 | 5.91 | 91247.00 |
| Aug 07, 2026 | 6.12 | 6.17 | 5.775 | 5.93 | 124474.0 |
| Aug 06, 2026 | 5.82 | 6.26 | 5.81 | 6.08 | 207261.0 |
| Aug 05, 2026 | 5.94 | 5.99 | 5.71 | 5.84 | 145950.0 |
| Aug 04, 2026 | 5.65 | 6.145 | 5.52 | 5.94 | 368377.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.23 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0003 |
| Arvinas, Inc. | 8.845 |
| Fulcrum Therapeutics, Inc. | 3.795 |
Price Related Metrics
| Price to Book Value | 2.745 |
| Earnings Yield | -18.70% |
| Market Cap | 208.41M |